HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Zhou Selected Research

4-chlorophenol

6/2014Carboxymethyl cellulose coating decreases toxicity and oxidizing capacity of nanoscale zerovalent iron.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Zhou Research Topics

Disease

244Neoplasms (Cancer)
08/2022 - 07/2006
67Neoplasm Metastasis (Metastasis)
08/2022 - 01/2010
63Infections
10/2022 - 08/2002
45Breast Neoplasms (Breast Cancer)
07/2022 - 12/2005
36Inflammation (Inflammations)
01/2022 - 07/2007
33Hepatocellular Carcinoma (Hepatoma)
05/2022 - 10/2007
25Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2010
16Carcinogenesis
12/2021 - 10/2011
16Carcinoma (Carcinomatosis)
01/2021 - 12/2009
15Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 02/2014
15Lymphatic Metastasis
05/2022 - 06/2012
14Insulin Resistance
07/2022 - 02/2006
14Fibrosis (Cirrhosis)
01/2022 - 11/2015
13Obesity
07/2022 - 09/2006
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 09/2009
13Myasthenia Gravis
01/2022 - 09/2017
11Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2015
11Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 06/2012
11Stomach Neoplasms (Stomach Cancer)
01/2021 - 07/2006
10Neuromyelitis Optica (Devic's Disease)
05/2022 - 01/2019
10Fatty Liver
01/2022 - 01/2016
10Dry Eye Syndromes (Dry Eye Syndrome)
01/2021 - 11/2009
9Adenocarcinoma
05/2022 - 06/2012
9Lung Neoplasms (Lung Cancer)
04/2022 - 12/2008
9Pain (Aches)
01/2022 - 02/2011
9Cholangiocarcinoma
01/2022 - 01/2018
9Hypertension (High Blood Pressure)
01/2022 - 07/2015
9Nasopharyngeal Carcinoma
01/2021 - 07/2015
8Glioma (Gliomas)
10/2022 - 01/2012
8Wounds and Injuries (Trauma)
01/2022 - 01/2003
8Leukemia
11/2019 - 02/2014
8Plague (Bubonic Plague)
01/2016 - 10/2009
7Virus Diseases (Viral Diseases)
09/2022 - 08/2014
7Hypoxia (Hypoxemia)
07/2022 - 01/2011
7Colonic Neoplasms (Colon Cancer)
01/2022 - 10/2016
7Body Weight (Weight, Body)
10/2021 - 09/2012
7Ovarian Neoplasms (Ovarian Cancer)
09/2021 - 03/2012
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 01/2015
6Triple Negative Breast Neoplasms
08/2022 - 01/2018
6Atrial Fibrillation
01/2022 - 01/2016
6Hemorrhage
01/2022 - 08/2006
6Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 07/2012
6Diarrhea
01/2022 - 01/2017
6Non-alcoholic Fatty Liver Disease
10/2021 - 01/2019
5Prostatic Neoplasms (Prostate Cancer)
12/2022 - 01/2013
5Autoimmune Diseases (Autoimmune Disease)
10/2022 - 10/2013

Drug/Important Bio-Agent (IBA)

101Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2002
64Biomarkers (Surrogate Marker)IBA
07/2022 - 11/2005
37Pharmaceutical PreparationsIBA
08/2022 - 09/2010
28MicroRNAs (MicroRNA)IBA
06/2022 - 05/2014
27Biological ProductsIBA
07/2022 - 07/2007
23EnzymesIBA
01/2022 - 02/2012
20AntibodiesIBA
10/2022 - 04/2009
20Small Interfering RNA (siRNA)IBA
01/2022 - 12/2009
18Glucose (Dextrose)FDA LinkGeneric
10/2022 - 01/2011
17RNA (Ribonucleic Acid)IBA
10/2022 - 02/2008
16VaccinesIBA
10/2022 - 10/2009
14CytokinesIBA
10/2022 - 08/2011
14Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2005
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 01/2011
11Peptides (Polypeptides)IBA
12/2022 - 09/2007
11Cisplatin (Platino)FDA LinkGeneric
04/2022 - 04/2013
11HydrogelsIBA
01/2022 - 12/2015
11Long Noncoding RNAIBA
01/2022 - 06/2017
11Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2011
11DNA (Deoxyribonucleic Acid)IBA
11/2021 - 08/2010
11Messenger RNA (mRNA)IBA
01/2021 - 06/2009
10LipidsIBA
07/2022 - 01/2013
10Retinaldehyde (Retinal)IBA
07/2022 - 09/2013
10Interleukin-6 (Interleukin 6)IBA
12/2021 - 07/2007
9Rituximab (Mabthera)FDA Link
01/2022 - 10/2017
9Circular RNAIBA
01/2022 - 01/2018
9AntigensIBA
01/2022 - 03/2002
9Therapeutic UsesIBA
11/2021 - 02/2011
9LigandsIBA
01/2021 - 12/2005
8Myelin-Oligodendrocyte GlycoproteinIBA
07/2022 - 11/2019
8ResistinIBA
06/2017 - 02/2006
7Insulin (Novolin)FDA Link
05/2022 - 04/2007
7CollagenIBA
01/2022 - 12/2015
7Indicators and Reagents (Reagents)IBA
09/2021 - 05/2009
7Cadherins (E-Cadherin)IBA
01/2021 - 11/2013
7Phosphotransferases (Kinase)IBA
01/2021 - 01/2013
6Doxorubicin (Adriamycin)FDA LinkGeneric
08/2022 - 05/2011
6PolymersIBA
01/2022 - 05/2011
6Immune Checkpoint InhibitorsIBA
01/2022 - 11/2019
6Sorafenib (BAY 43-9006)FDA Link
01/2022 - 06/2012
6CateninsIBA
11/2021 - 02/2014
6ChromatinIBA
08/2021 - 10/2011
6Immunoglobulin G (IgG)IBA
12/2020 - 02/2010
6Protein Isoforms (Isoforms)IBA
04/2020 - 07/2010
6Estrogen ReceptorsIBA
01/2019 - 12/2005
6tear proteinsIBA
11/2018 - 01/2003

Therapy/Procedure

82Therapeutics
04/2022 - 08/2002
28Drug Therapy (Chemotherapy)
02/2021 - 01/2012
24Immunotherapy
10/2022 - 04/2009
14Radiotherapy
01/2022 - 01/2012
8Transplantation
01/2022 - 01/2010
8Lasers (Laser)
12/2019 - 03/2009
6Precision Medicine
09/2021 - 01/2016
6Stents
08/2021 - 01/2017